CHANGES IN DOPAMINE-MEDIATED BEHAVIOUR DURING ONE YEAR'S NEUROLEPTIC ADMINISTRATIONCLOW A; JENNER P; MARSDEN CD et al.1979; EUROP. J. PHARMACOL.; NLD; DA. 1979; VOL. 57; NO 4; PP. 365-375; BIBL. 2 P.Article

AN EXPERIMENTAL MODEL OF TARDIVE DYSKINESIASCLOW A; JENNER P; MARSDEN CD et al.1978; LIFE SCI.; GBR; DA. 1978; VOL. 22; NO 5; PP. 421-424; BIBL. 8 REF.Conference Paper

CHANGES IN RAT STRIATAL DOPAMINE TURNOVER AND RECEPTOR ACTIVITY DURING ONE YEARS NEUROLEPTIC ADMINISTRATIONCLOW A; THEODOROU A; JENNER P et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 63; NO 2-3; PP. 135-144; BIBL. 19 REF.Article

STEREOSELECTIVE ACTIONS OF SUBSTITUTED BENZAMIDE DRUGS ON CEREBRAL DOPAMINE MECHANISMSJENNER P; CLOW A; REAVILL C et al.1980; J. PHARM. PHARMACOL.; GBR; DA. 1980; VOL. 32; NO 1; PP. 39-44; BIBL. 25 REF.Article

A COMPARISON OF STRIATAL AND MESOLIMBIC DOPAMINE FUNCTION IN THE RAT DURING 6-MONTH TRIFLUOPERAZINE ADMINISTRATIONCLOW A; THEODOROU A; JENNER P et al.1980; PSYCHOPHARMACOLOGY; DEU; DA. 1980; VOL. 69; NO 3; PP. 227-233; BIBL. 24 REF.Article

A COMPARISON OF IN VITRO AND IN VIVO DOPAMINE RECEPTOR ANTAGONISM PRODUCED BY SUBSTITUTED BENZAMIDE DRUGS.JENNER P; ELLIOTT PNC; CLOW A et al.1978; J. PHARM. PHARMACOL.; G.B.; DA. 1978; VOL. 30; NO 1; PP. 46-48; BIBL. 10 REF.Article

CEREBRAL DOPAMINE FUNCTION IN RATS FOLLOWING WITHDRAWAL FROM ONE YEAR OF CONTINUOUS NEUROLEPTIC ADMINISTRATIONCLOW A; THEODOROU A; JENNER P et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 63; NO 2-3; PP. 145-157; BIBL. 1 P.Article

STRIATAL DOPAMINE RECEPTORS BECOME SUPERSENSITIVE WHILE RATS ARE GIVEN TRIFLUOPERAZINE FOR SIX MONTHSCLOW A; JENNER P; THEODOROU A et al.1979; NATURE; GBR; DA. 1979; VOL. 278; NO 5699; PP. 59-61; BIBL. 19 REF.Article

A BEHAVIOURAL AND BIOCHEMICAL COMPARISON OF DOPAMINE RECEPTOR BLOCKADE PRODUCED BY HALOPERIDOL WITH THAT PRODUCED BY SUBSTITUTED BENZAMIDE DRUGS.JENNER P; CLOW A; REAVILL C et al.1978; LIFE SCI.; GBR; DA. 1978; VOL. 23; NO 6; PP. 545-550; BIBL. 8 REF.Article

NEUROLEPTIC-INDUCED ACUTE DYSTONIC REACTIONS MAY BE DUE TO ENHANCED DOPAMINE RELEASE ON TO SUPERSENSITIVE POSTSYNAPTIC RECEPTORSKOLBE H; CLOW A; JENNER P et al.1981; NEUROLOGY; ISSN 0028-3878; USA; DA. 1981; VOL. 31; NO 4; PART. 1; PP. 434-439; BIBL. 25 REF.Article

ANTAGONISM BY PROPRANOLOL OF CENTRAL DOPAMINE RECEPTOR STIMULATION IS NON RELATED TO BETA -ADRENERGIC BLOCKADELUSCOMBE G; CLOW A; JENNER P et al.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 5; PP. 355-356; BIBL. 14 REF.Article

CHRONIC NEUROLEPTIC TREATMENT SPECIFICALLY ALTERS THE NUMBER OF DOPAMINE RECEPTORS IN RAT BRAINTHEODOROU A; GOMMEREN W; CLOW A et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 14; PP. 1621-1627; BIBL. 25 REF.Article

CHRONIC CONTINUOUS ADMINISTRATION OF NEUROLEPTIC DRUGS ALTERS CEREBRAL DOPAMINE RECEPTORS AND INCREASES SPONTANEOUS DOPAMINERGIC ACTION IN THE STRIATUMMURUGAIAH K; THODOROU A; MANN S et al.1982; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1982; VOL. 296; NO 5857; PP. 570-572; BIBL. 16 REF.Article

RAISED ENDOGENOUS MONOAMINE OXIDASE INHIBITOR OUTPUT IN POSTWITHDRAWAL ALCOHOLICS: EFFECTS OF L-DOPA AND ETHANOLBHATTACHARYA SK; GLOVER V; SANDLER M et al.1982; BIOL. PSYCHIATRY; ISSN 0006-3223; USA; DA. 1982; VOL. 17; NO 7; PP. 829-836; BIBL. 16 REF.Article

DURING ONE YEAR'S NEUROLEPTIC TREATMENT IN RATS STRIATAL DOPAMINE RECEPTOR BLOCKHADE DECREASES BUT SERUM PROLACTIN LEVELS REMAIN ELEVATEDDYER RG; MURUGAIAH K; THEODOROU A et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 2; PP. 167-174; BIBL. 28 REF.Article

Suspected non-adherence and weekend versus week day differences in the awakening cortisol responseTHORN, L; HUCKLEBRIDGE, F; EVANS, P et al.Psychoneuroendocrinology. 2006, Vol 31, Num 8, pp 1009-1018, issn 0306-4530, 10 p.Article

Association between time of awakening and diurnal cortisol secretory activityEDWARDS, S; EVANS, P; HUCKLEBRIDGE, F et al.Psychoneuroendocrinology. 2001, Vol 26, Num 6, pp 613-622, issn 0306-4530Article

Increased urinary tribulin output in generalised anxiety disorderCLOW, A; GLOVER, V; SANDLER, M et al.Psychopharmacologia. 1988, Vol 95, Num 3, pp 378-380, issn 0033-3158Article

The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakeningHUCKLEBRIDGE, F; HUSSAIN, T; EVANS, P et al.Psychoneuroendocrinology. 2005, Vol 30, Num 1, pp 51-57, issn 0306-4530, 7 p.Article

The relationship between salivary secretory immunoglobulin A and cortisol : neuroendocrine response to awakening and the diurnal cycleHUCKLEBRIDGE, F; CLOW, A; EVANS, P et al.International journal of psychophysiology. 1998, Vol 31, Num 1, pp 69-76, issn 0167-8760Article

Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease : a role for superoxide dismutase ?SANDLER, M; GLOVER, V; CLOW, A et al.Advances in neurology. 1993, Vol 60, pp 238-241, issn 0091-3952Article

Tribulin output in neurological disordersCLOW, A; GLOVER, V; SANDLER, M et al.British journal of clinical pharmacology. 1987, Vol 24, Num 3, pp 403-404, issn 0306-5251Article

Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam bindingCLOW, A; GLOVER, V; SANDLER, M et al.Journal of neurochemistry. 1985, Vol 45, Num 2, pp 621-625, issn 0022-3042Article

New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor?CLOW, A; GLOVER, V; ARMANDO, I et al.Life sciences (1973). 1983, Vol 33, Num 8, pp 735-741, issn 0024-3205Article

The effect of dawn simulation on the cortisol response to awakening in healthy participantsTHORN, L; HUCKLEBRIDGE, F; ESGATE, A et al.Psychoneuroendocrinology. 2004, Vol 29, Num 7, pp 925-930, issn 0306-4530, 6 p.Article